Pressmeddelanden, rapporter och bolagsmeddelande för Hamlet BioPharma B
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma Participates in The Global Forum 2024
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Reports: Q3 Interim Report January - March 2024
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma bjuder in till investerarträff
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Clinical data from patients with bladder pain syndrome support anakinra (IL1-RA) as a new, successful treatment option
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma secures large scale Alpha1 peptide production in an agreement with Polypeptide Group
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Alpha1H to be the first asset for the commercial collaboration
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Immune responses in patients treated with Alpha1H - results published in the journal Cancer Medicine
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Analys av immunsvar hos patienter behandlade med Alpha1H publiceras i tidskriften Cancer Medicine
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma arranges a new series of digital events
Spotlight News
Nyhetsuppdatering från Hamlet BioPharma B
Press release from Companies: Hamlet BioPharma Participates in Økonomisk Ugebrev’s Life Science Investor Konference 2024